| 000 | 01460 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518050240.0 | ||
| 264 | 0 | _c20191224 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1011-601X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAkhtar, Usman | |
| 245 | 0 | 0 |
_aHepatoprotective effect of ketoconazole in chronic liver injury model. _h[electronic resource] |
| 260 |
_bPakistan journal of pharmaceutical sciences _cMay 2019 |
||
| 300 |
_a1033-1042 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aActins _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarbon Tetrachloride _xtoxicity |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aHepatocytes _xdrug effects |
| 650 | 0 | 4 |
_aKetoconazole _xpharmacology |
| 650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xmetabolism |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xchemically induced |
| 650 | 0 | 4 | _aLiver Function Tests |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xgenetics |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aProtective Agents _xpharmacology |
| 700 | 1 | _aAhmed, Mobasher | |
| 700 | 1 | _aTayyeb, Asima | |
| 700 | 1 | _aShehzad, Umara | |
| 700 | 1 | _aAli, Gibran | |
| 773 | 0 |
_tPakistan journal of pharmaceutical sciences _gvol. 32 _gno. 3 _gp. 1033-1042 |
|
| 999 |
_c29874784 _d29874784 |
||